Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

Well greekman, the NHS will have to spend their money even more wisely now we find that one of the last acts as chancellor our new PM reduced NHS funding by 2billion, from 6.2b to 4.2b. Now that's a good start for sorting the NHS out--NOT. In England we cannot receive Rituximab (for Rheumatoid Arthritis) on the NHS, but guess what - in Scotland they can.
2517

Hi George,

Yes, I had noticed the reduction in funding, but if I remember correctly, the amount put in for the sole intention of reducing the debt was almost equal with the drop in funding. The debt of the NHS trusts has according to the Government been eradicated. I think the figures as usual have been fiddled, and no matter what the government tell us, huge amounts of cash have been saved due to vast reductions in treatments, operations. In our area, you now go on an unofficial waiting list to get on the official waiting list.
But I do think as you say, finance accountability, spending more wisely will have to sustain the finance reduction.

Lets hope common sense comes more into spending decisions, IE spend to save.

Problem is does common sense and Government decisions don't go together.

As to the Scottish patient, receiving a better deal than the rest of the UK, I can't agree with you more. As we all know this unequalness is there in many areas, not just health.

Wont go further down this road as I don't want to go too far from the threads theme.

I think, I will buy a caravan, move to Scotland, change my name to Jock McTavish, wear a kilt and have haggis for breakfast. (I do love haggis).

So wishing you, "Och I The New". (No I can't spell and my spell checker gave up, and I don't know what it means).

"Och Aye" - Oh Yes
"The Noo" - Now

How's that? Spell checkers be damned.

Thanks Arf,

Knew someone would put me right. Clever ***.
At least I am better at picking shares (not by much) than I am at spelling.

Charles Stanley reiterated its "Buy" stance for Deltex Medical (DEMG), citing the potential for revenue growth of 40% for the three years to 2009 and the company's plausible attraction as a takeover target. However, its shares shed 0.75p to 27.5p.

Still out of favor with the market, but I think the Charles Stanley projection is on the conservative side.

Yet another report on the benefits of CardioQ.
2517

Yes as you say yet another, although you can't really have too many, but how many more are required before the NHS mis-managers get their very dim fingers out and buy the b****y thing. They remind me of those three monkeys, hear nowt, say nowt, see nowt,( yes I know it was a bit of poetic license).

Still think the first real big NHS contract will come this year, which will start the ball rolling.

There has to be plenty in the pipeline, due to the extra capacity, Deltex are gearing up to.

greekman -------- With DEMG gearing up to cope with demand ahead of that demand, I believe it shows the forward thinking management are in front of the curve, and that DEMG will be ready for the increase in capacity as it materialises, as it surely will.
2517

Trading update looks promising. Sales well on track and steadily increasing. The next 6/12 months look to have even more potential.

I was sitting out in the sun reading the newspaper, when the news from Deltex came in re pre-close update on the six months ended 30 June 2007, now that news was first class, much better than the newspaper. Establishing the use of the Cardio system, US market increased by approximately half since the start of the year. At shareclubuk.co.uk the out-of -town members are saying that DEMG has the right product sales now to soon be into profits. Both UK and US sales are up, this on its own must be a step in the right direction.

Myway,

Sorry to go off subject, but "sitting out in the sun". Where, when?

Looks like an '04 repeat..... Lets see if the sp can break 34p with this climb...!

Nice piece in shares today.
2517

RNS,

Recommendation for CardioQ,

The Planned Care Clinical Working Group was established to report into the
Healthcare for London Review. This review was led by Sir Ara Darzi, who was
recently appointed a minister at the Department of Health, with responsibility
for conducting the national NHS Next Stage review.

Sir Darzi did not waste much time compiling this very intensive report.
I have looked through it but did not see the CardioQ referred to by name, just the increased use of oesophageal Doppler monitoring. As the CardioQ has been the most successful in test concluded in London Hospitals it obviously (I hope) refers to the CardioQ by inference.

Lets just hope the Government take note. (See my post 459 first referring to Sir Darzi).
.

I believe it's just a matter of time, hopefully not too much though. The 30.45p deals are buys.
2517

This is rather disappointing.
2517

Another chance for Deltex to push the CardioQ.

Innovative MedTech Companies Selected to Present to Collaborators, Strategic Partners, and Investors at AdvaMed 2007


http://sev.prnewswire.com/health-care-hospitals/20070823/DCTH00823082007-1.html

How many more chances does this company need, maybe if everyone got behind and pushed............. Agreed budding business and great model but you gotta question the management and not the NHS over flat sales...

explosive--------It takes time to build up sales, I am as disappointed as yourself especially as the sp has retreated from 31p since the end of july. I would not be too quick to blame the management though.
2517

Results.

No real surprises. It's steady as she goes. Still awaiting that big order jump, although nice to see the USA increasingly in on the act.
The only thing that bothers me is the cash situation. Although cash burn is reducing, the cushion is a bit low for comfort. In total I feel we need as much patience as the Deltex management appear to have.
Looks like a HOLD.